Quantifying Biomarkers in the Eye for Better Clinical Outcomes

Zilia is developing a groundbreaking technology bound to redefine the way we prevent, diagnose, and treat various ocular, neurological, and systemic conditions.

Zilia’s technology provides health care professionals with new key clinical insight.

Why the Eye?

The eye is a unique window into a person’s health. In fact, due to its relationship to the brain and the vascular system, the eye is an ideal setting to non-invasively monitor biomarkers related to ocular, neurological, and systemic diseases.


New Data Through Optics and AI

We are developing a groundbreaking technology using imaging, spectrometry, and AI to identify and quantify biomarkers in the eye.

Quantifying Oxygen Saturation in the Eye

Zilia Ocular is the first non-invasive technology to provide continuous measurements of oxygenation in the human eye.


What if we Could Prevent Vision Loss?

As oxygenation of the retina is a crucial biomarker in the leading causes of vision loss, such as glaucoma, diabetic retinopathy, and age-related macular degeneration, our first product is bound to revolutionize the prevention, diagnosis, and management of these diseases and save people’s eyesight in the process.

Our Partners